Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2023-02-28 Sale |
2023-03-02 4:30 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
10,000 | $273.24 | $2,732,438 | 60,667 (Direct) |
View |
| 2023-01-17 Sale |
2023-01-19 7:57 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Levy Richard S Director |
22,489 | $293.15 | $6,592,686 | 9,100 (Direct) |
View |
| 2023-01-03 Sale |
2023-01-06 09:08 am |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Lynch Brian Joseph SVP and General Counsel |
13,000 | $282.92 | $3,677,977 | 12,530 (Indirect Direct) |
View |
| 2022-12-23 Sale |
2022-12-28 8:00 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Lynch Brian Joseph SVP and General Counsel |
7,000 | $274.18 | $1,919,231 | 25,530 (Indirect Direct) |
View |
| 2022-12-23 Sale |
2022-12-28 8:00 pm |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Sukhija Remy Chief Commercial Officer |
30,000 | $274.14 | $8,224,073 | 30,000 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2023-06-15 Option Award |
2023-06-20 6:47 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Levy Richard S Director |
1,198 | $0 | 10,298 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 6:46 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | CRAVES FRED B Director |
1,198 | $0 | 1,982,338 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 6:41 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Daly James M Director |
1,198 | $0 | 1,198 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 6:41 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director |
1,198 | $0 | 1,198 (Direct) |
View |
| 2023-06-15 Option Award |
2023-06-20 4:10 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director |
4,792 | $0 | 1,401,084 (Indirect) |
View |
Ownership |
2023-06-20 06:17 am |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | BAKER BROS. ADVISORS LP 667 L.P. BAKER JULIAN BAKER FELIX Baker Bros. Advisors (GP) LLC Baker Brothers Life Sciences LP Director |
0 | $0 | 3,914,910 (Indirect) |
View |
| 2023-02-28 Exercise |
2023-03-02 4:30 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
10,000 | $87.92 | 60,667 (Direct) |
View |
| 2023-02-28 Exercise |
2023-03-02 4:30 pm |
N/A 2031-08-02 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
10,000 | $0 | 60,667 (Direct) |
View |
| 2023-01-17 Exercise |
2023-01-19 7:57 pm |
N/A 2024-06-17 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Levy Richard S Director |
22,489 | $0 | 9,100 (Direct) |
View |
| 2023-01-17 Exercise |
2023-01-19 7:57 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Levy Richard S Director |
10,000 | $100.45 | 9,100 (Direct) |
View |
| 2023-01-17 Exercise |
2023-01-19 7:57 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Levy Richard S Director |
12,489 | $105.08 | 9,100 (Direct) |
View |
| 2023-01-16 Option Award |
2023-01-18 8:00 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Sukhija Remy Chief Commercial Officer |
15,001 | $0 | 15,001 (Direct) |
View |
| 2023-01-16 Option Award |
2023-01-18 8:00 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
5,667 | $0 | 5,667 (Direct) |
View |
| 2023-01-16 Option Award |
2023-01-18 8:00 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Lynch Brian Joseph SVP and General Counsel |
15,001 | $0 | 15,531 (Direct) |
View |
| 2023-01-16 Option Award |
2023-01-18 8:00 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Howarth Alex G. Chief Financial Officer |
15,001 | $0 | 15,001 (Direct) |
View |
| 2023-01-16 Option Award |
2023-01-18 8:00 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Chief Executive Officer |
26,668 | $0 | 843,529 (Direct) |
View |
| 2023-01-16 Option Award |
2023-01-18 8:00 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca Pres., R&D, and CMO |
20,001 | $0 | 1,110,299 (Direct) |
View |
| 2023-01-03 Exercise |
2023-01-06 09:08 am |
N/A 2030-03-05 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Lynch Brian Joseph SVP and General Counsel |
13,000 | $0 | 12,530 (Direct) |
View |
| 2023-01-03 Exercise |
2023-01-06 09:08 am |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Lynch Brian Joseph SVP and General Counsel |
13,000 | $91.79 | 12,530 (Direct) |
View |
| 2022-12-23 Exercise |
2022-12-28 8:00 pm |
N/A 2030-03-05 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Lynch Brian Joseph SVP and General Counsel |
7,000 | $0 | 25,530 (Direct) |
View |
| 2022-12-23 Exercise |
2022-12-28 8:00 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Lynch Brian Joseph SVP and General Counsel |
7,000 | $91.79 | 25,530 (Direct) |
View |
| 2022-12-23 Exercise |
2022-12-28 8:00 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Sukhija Remy Chief Commercial Officer |
30,000 | $60.26 | 30,000 (Direct) |
View |
| 2022-12-23 Exercise |
2022-12-28 8:00 pm |
N/A 2030-04-01 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Sukhija Remy Chief Commercial Officer |
30,000 | $0 | 30,000 (Direct) |
View |
| 2022-08-10 Option Award |
2022-08-12 4:30 pm |
N/A 2032-08-10 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Lynch Brian Joseph SVP and General Counsel |
25,000 | $0 | 25,000 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-21 06:30 am |
N/A 2025-06-16 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | BATE KENNETH Director |
9,470 | $0 | 9,470 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-21 06:30 am |
N/A 2025-06-16 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | MILLIGAN DAVID V Director |
9,470 | $0 | 9,470 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-21 06:30 am |
N/A 2025-06-16 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | CRAVES FRED B Director |
9,470 | $0 | 9,470 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-21 06:30 am |
N/A 2025-06-16 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Levy Richard S Director |
9,470 | $0 | 9,470 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-21 06:30 am |
N/A 2025-06-16 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Daly James M Director |
9,470 | $0 | 9,470 (Direct) |
View |
| 2022-06-16 Option Award |
2022-06-21 06:30 am |
N/A 2025-06-16 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Gollust Keith R Director |
9,470 | $0 | 9,470 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 8:40 pm |
N/A 2032-02-22 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Howarth Alex G. Chief Financial Officer |
45,000 | $0 | 45,000 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 8:18 pm |
N/A 2032-02-22 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Lynch Brian Joseph SVP and General Councel |
45,000 | $0 | 45,000 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 8:18 pm |
N/A 2032-02-22 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Sukhija Remy Chief Commercial Officer |
45,000 | $0 | 45,000 (Direct) |
View |
| 2022-02-24 Option Award |
2022-02-24 8:17 pm |
N/A 2022-02-24 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
12,250 | $0 | 12,250 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 8:12 pm |
N/A 2032-02-22 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Taub Rebecca See Remarks |
61,500 | $0 | 61,500 (Direct) |
View |
| 2022-02-22 Option Award |
2022-02-24 8:10 pm |
N/A 2032-02-22 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | FRIEDMAN PAUL A Chief Executive Officer |
70,000 | $0 | 70,000 (Direct) |
View |
Ownership |
2022-02-02 4:05 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | CRAVES FRED B Director 10% Owner |
0 | $0 | 1,981,140 (Indirect) |
View |
| 2021-12-31 Ownership |
2022-02-02 4:05 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | CRAVES FRED B Director 10% Owner |
3,000 | $0 | 1,981,140 (Direct) |
View |
| 2021-12-03 Other |
2021-12-07 4:30 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | BAY CITY CAPITAL LLC Bay City Capital Management IV LLC Bay City Capital Fund IV L.P. BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP 10% Owner |
824,172 | $0 | 825,433 (Indirect) |
View |
| 2021-12-03 Other |
2021-12-07 4:30 pm |
N/A N/A |
MADRIGAL PHARMACEUTICALS INC. | MDGL | CRAVES FRED B Director 10% Owner |
824,172 | $0 | 1,294,791 (Indirect) |
View |
| 2021-11-01 Option Award |
2021-11-03 4:26 pm |
N/A 2031-11-01 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Howarth Alex G. Chief Financial Officer |
5,000 | $0 | 5,000 (Direct) |
View |
| 2021-08-02 Option Award |
2021-08-04 9:46 pm |
N/A 2031-08-02 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Waltermire Robert E. Senior VP, Chief Pharma Dev. |
35,000 | $0 | 35,000 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-21 08:03 am |
N/A 2024-06-17 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | Daly James M Director |
12,489 | $0 | 12,489 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-21 08:03 am |
N/A 2024-06-17 |
MADRIGAL PHARMACEUTICALS INC. | MDGL | CRAVES FRED B Director |
12,489 | $0 | 12,489 (Direct) |
View |